CCNA2 is related to the cell cycle and has been suggested as a possible molecular marker in low-grade gliomas (Qi et al., 2020), and plays a regulatory role in the development of various kinds of cancer (Zhou et al., 2024). The gene discussed is CCNA2; the disease is central nervous system cancer.